Effectiveness and safety of the monoclonal antibody drug lecanemab (Leqembi) in reducing beta-amyloid plaques in alzheimer’s dementia: a literature review. JOHMPE [Интернет]. 27 февраль 2025 г. [цитируется по 25 август 2026 г.];3(1). доступно на: https://shmpublisher.com/index.php/johmpe/article/view/547